1. Захарова А.С., Сесь Т.П., Новикова Л.Н. и др. Иммунологические критерии активности хронического воспалительного процесса у больных с идиопатическим фиброзирующим альвеолитом. МЕДЛАЙН-ЭКСПРЕСС, 2006; 2–3 (186): 17–20.
2. Илькович М.М., Новикова Л.Н., Двораковская И.В. Идиопатический фиброзирующий альвеолит: противоречия в современных представлениях. Бол. орг. дых. 2009; 1: 3–8.
3. Каменева М.Ю. Исследование функции внешнего дыхания. В кн.: Интерстициальные заболевания легких. Руководство для врачей. Под ред. М.М.Ильковича, А.Н.Кокосова. Санкт-Петербург: Нордмедиздат, 2005; с. 50–9.
4. Путов Н.В., Илькович М.М. Фиброзирующие альвеолиты. Л.: Медицина, 1986.
5. Acharya PS, Zisman DA. Antifibrotic therapy for idiopathic pulmonary fibrosis. Clin Pulmon Med 2001; 8 (6): 327–34.
6. Amthor M. Die Stellung der Liebowschen Desquamativpneumonia interhalb der chronischen interstitiellen Pneumonien. Prax Pneum 1979; 33: 647–50.
7. Baumgartner KB, Samet JM, Coultas DB et al. Occupational and Environmental Risk Factors for Idiopathic Pulmonary Fibrosis: A Multicenter Case-Control Study. Am J Epidemiol 2000; 152 (4): 307–15.
8. Diaz JI, Ouellette DR. Pulmonary Fibrosis, Idiopathic. Article Last Updated: Mar 7, 2008.
9. Freudenberger T, Raghu J. Idiopathic pulmonary fibrosis: an evolving approach to diagnosis and treatment. In: Europen Respiratory Monograph «Interstitial Lung Diseases». 2000; 5: 79–96.
10. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. ATS and ERS. Am J Respir Crit Care Med 2000; 16: 646–64.
11. Katzenstein A, Myers J. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301–15.
12. Khalil NO, O'Connor R. Idiopathic Pulmonary Fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ 2004; 356: 153–60.
13. Kuwano K, Nakashima N, Inoshima I et al. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J 2003; 216: 232–40.
14. Lawson WE, Loyd JE. The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease? Proc Am Thorac Soc 2006; 3 (4): 345–9.
15. Liebow AA, Smith DE. New concepts and entities in pulmonary disease. In: The Lung, hrsg. von A.A.Liebow. Williams & Wilkins. Baltimore, 1968.
16. Liebow AA, Steer A, Billingsley JG. Desqamative interstitisl pneumonia. Am J Med 1965; 39: 369.
17. Malizia AP, Keating DT, Smith SM et al. Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGF1 expression. Am J Physiol Lung Cell Mol Physiol 2008; 295: 451–60.
18. Raghu G, Weyeker D, Edelsberg J et al. Incidence and Prevalence of Idiopathic Pulmonary Fibrosis. Am J Respir Critical Care Med 2006; 174: 810–6.
19. Scadding JG. Fibrosing alveolitis. BMJ 1964; 2: 686.
20. Scadding JG, Hinson K. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967; 22: 291–304.
21. Selman M, Talmadge E, King E, Pardo A. Idiopathic pulmonary fibrosis: Prevailing and Evolving Hypotheses about its Pathogenesis and Implications for Therapy. Ann Intern Med 2001; 134: 136–51.
22. Taskar VS, Coultas DB. Is Idiopathic Pulmonary Fibrosis an Environmental Disease? The American Thoracic Society 2006; 3: 293–8.